136 related articles for article (PubMed ID: 14699495)
41. Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription.
Subbaramaiah K; Bulic P; Lin Y; Dannenberg AJ; Pasco DS
J Biomol Screen; 2001 Apr; 6(2):101-10. PubMed ID: 11689104
[TBL] [Abstract][Full Text] [Related]
42. KG-135 inhibits COX-2 expression by blocking the activation of JNK and AP-1 in phorbol ester-stimulated human breast epithelial cells.
Park SA; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2007 Jan; 1095():545-53. PubMed ID: 17404068
[TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase-2 inhibitor nimesulide suppresses telomerase activity by blocking Akt/PKB activation in gastric cancer cell line.
Baoping Y; Guoyong H; Jieping Y; Zongxue R; Hesheng L
Dig Dis Sci; 2004 Jun; 49(6):948-53. PubMed ID: 15309882
[TBL] [Abstract][Full Text] [Related]
44. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
Manna SK; Aggarwal BB
J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
[TBL] [Abstract][Full Text] [Related]
45. Essential role of c-Jun induction and coactivator p300 in epidermal growth factor-induced gene expression of cyclooxygenase-2 in human epidermoid carcinoma A431 cells.
Chen LC; Chen BK; Chang JM; Chang WC
Biochim Biophys Acta; 2004 Jul; 1683(1-3):38-48. PubMed ID: 15238218
[TBL] [Abstract][Full Text] [Related]
46. Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis.
Shishodia S; Koul D; Aggarwal BB
J Immunol; 2004 Aug; 173(3):2011-22. PubMed ID: 15265936
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes.
Scherle PA; Jones EA; Favata MF; Daulerio AJ; Covington MB; Nurnberg SA; Magolda RL; Trzaskos JM
J Immunol; 1998 Nov; 161(10):5681-6. PubMed ID: 9820549
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
49. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G
Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826
[TBL] [Abstract][Full Text] [Related]
50. Rhein inhibits TPA-induced activator protein-1 activation and cell transformation by blocking the JNK-dependent pathway.
Lin S; Li JJ; Fujii M; Hou DX
Int J Oncol; 2003 Apr; 22(4):829-33. PubMed ID: 12632075
[TBL] [Abstract][Full Text] [Related]
51. AgC10, a mucin from Trypanosoma cruzi, destabilizes TNF and cyclooxygenase-2 mRNA by inhibiting mitogen-activated protein kinase p38.
Alcaide P; Fresno M
Eur J Immunol; 2004 Jun; 34(6):1695-704. PubMed ID: 15162440
[TBL] [Abstract][Full Text] [Related]
52. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
Manna SK; Mukhopadhyay A; Aggarwal BB
J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
[TBL] [Abstract][Full Text] [Related]
53. Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells.
Chen Y; Wu Q; Song SY; Su WJ
World J Gastroenterol; 2002 Dec; 8(6):1014-8. PubMed ID: 12439916
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300.
Subbaramaiah K; Lin DT; Hart JC; Dannenberg AJ
J Biol Chem; 2001 Apr; 276(15):12440-8. PubMed ID: 11278336
[TBL] [Abstract][Full Text] [Related]
55. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
56. Activation of c-Jun-N-terminal-kinase is crucial for the induction of a cell cycle arrest in human colon carcinoma cells caused by flurbiprofen enantiomers.
Grösch S; Tegeder I; Schilling K; Maier TJ; Niederberger E; Geisslinger G
FASEB J; 2003 Jul; 17(10):1316-8. PubMed ID: 12759338
[TBL] [Abstract][Full Text] [Related]
57. Phosphoinositol 3-kinase, a novel target molecule for the inhibitory effects of juglone on TPA-induced cell transformation.
Chae JI; Cho JH; Kim DJ; Lee KA; Cho MK; Nam HS; Woo KM; Lee SH; Shim JH
Int J Mol Med; 2012 Jul; 30(1):8-14. PubMed ID: 22505246
[TBL] [Abstract][Full Text] [Related]
58. Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1).
Kyaw M; Yoshizumi M; Tsuchiya K; Kirima K; Suzaki Y; Abe S; Hasegawa T; Tamaki T
Biochem Pharmacol; 2002 Nov; 64(10):1521-31. PubMed ID: 12417265
[TBL] [Abstract][Full Text] [Related]
59. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9.
Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM
Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625
[TBL] [Abstract][Full Text] [Related]
60. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
